Roberto Moretto

7PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 13, 2026
Circulating Tumor DNA Dynamics in Patients with Liver-Limited Metastatic Colorectal Cancer Resected after First-Line Systemic Treatment.

Roberto Moretto, Vittorio Studiale, Seung Won Hyun

|Oct 14, 2023
Vessel-Guided Mesohepatectomy for Liver Partition and Staged Major Parenchyma-Sparing Hepatectomies with Super-Selective Portal Vein Embolization or Enhanced ALPPS to Achieve R0 Resection for Colorectal Liver Metastases at the Hepatocaval Confluence.

Lucio Urbani, Nicolò Roffi, Roberto Moretto

|Feb 09, 2023
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.

Roberto Moretto, Marco Maria Germani, Mirella Giordano

|Jun 06, 2022
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?

Roberto Moretto, Andrew Elliott, Daniele Rossini

|Apr 26, 2022
Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study.

Joleen M Hubbard, Enikő R Tőke, Roberto Moretto

|Jan 11, 2022
Immune Checkpoint Inhibitors in Mismatch Repair Proficient/Microsatellite Stable Metastatic Colorectal Cancer Patients: Insights from the AtezoTRIBE and MAYA Trials.

Marco Maria Germani, Roberto Moretto

Pageof 2

Frequent Collaborators

3 joint publications

Veronica Conca

3 joint publications

Filippo Pietrantonio

3 joint publications

Chiara Cremolini

2 joint publications

Sara Lonardi